Dan Shoemaker,Pratik S. Multani,John D. Mendlein,David Robbins
申请号:
US14362385
公开号:
US10111907B2
申请日:
2012.11.29
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The invention provides compositions comprising stem and/or progenitor cells that have been treated to enhance the therapeutic properties of the cells for treating ischemia. In particular, the present invention relates to the use of stem and/or progenitor cells having enhanced therapeutic properties to treat an ischemic tissue, a tissue damaged by ischemia, or at least one symptom associated with an ischemic tissue or a tissue damaged by ischemia.